Pursuant to the Merger Agreement, Mark J. Alles, Richard W. Barker, Hans Bishop, Michael W. Bonney, Michael D. Casey, Carrie S. Cox, Michael A. Friedman, Patricia Hemingway Hall, Julia A. Haller, James Loughlin, Ernest Mario and John H. Weiland each resigned from the board of directors of Celgene Corporation and from any and all committees of the board of directors on which they served and ceased to be directors of the company as of the Effective Time. At the Effective Time, Matthew Roden, P. Joseph Campisi, Jr. and Katherine R. Kelly, who were the directors of Merger Sub immediately prior to the Effective Time, became the directors of the company. In addition, as of the Effective Time, the company’s board of directors appointed Matthew Roden as President, P. Joseph Campisi, Jr. as Vice President, Jeffrey Galik as Treasurer and Katherine R. Kelly as Secretary.